Oncology Brothers: Practice-Changing Cancer Discussions cover image

FDA Approval of Zongertinib for HER2 Mutated Non-Small Cell Lung Cancer (NSCLC) - Dr. Joshua Sabari

Oncology Brothers: Practice-Changing Cancer Discussions

00:00

Intro

Hosts introduce Dr. Joshua Sabari and the topic: FDA approval of zongertinib for HER2-mutated NSCLC.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app